Timothy C R Prickett Selected Research

C-Type Natriuretic Peptide (Peptide, C-Type Natriuretic)

1/2022	Collagen X Marker Levels are Decreased in Individuals with Achondroplasia.
12/2021	Evidence of feedback regulation of C-type natriuretic peptide during Vosoritide therapy in Achondroplasia.
10/2019	Urinary Amino-Terminal Pro-C-Type Natriuretic Peptide: A Novel Marker of Chronic Kidney Disease in Diabetes.
10/2017	Central and systemic C-type Natriuretic Peptide are both reduced in Parkinson's Disease.
2/2015	C-type natriuretic peptide plasma levels are elevated in subjects with achondroplasia, hypochondroplasia, and thanatophoric dysplasia.
8/2013	Acute inflammation in young children inhibits C-type natriuretic peptide.
11/2012	C-Type Natriuretic Peptide (CNP) levels are altered in boys with Klinefelter syndrome.
7/2012	C-type Natriuretic Peptide: a novel biomarker of steroid induced bone toxicity in children with acute lymphoblastic leukemia (ALL).
8/2007	C-type natriuretic peptide forms in the ovine fetal and maternal circulations: evidence for independent regulation and reciprocal response to undernutrition.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Timothy C R Prickett Research Topics

Disease

3	Achondroplasia 01/2022 - 02/2015
2	Thanatophoric Dysplasia (Dwarfism, Thanatophoric) 01/2022 - 02/2015
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 01/2018
2	Coronary Artery Disease (Coronary Atherosclerosis) 01/2020 - 01/2017
2	Acute Coronary Syndrome 01/2020 - 01/2017
2	Inflammation (Inflammations) 10/2019 - 08/2013
2	Heart Failure 01/2019 - 01/2006
2	Maroteaux type Acromesomelic dysplasia 02/2015 - 04/2006
1	Diabetes Mellitus 01/2022
1	Body Weight (Weight, Body) 01/2022
1	Hypertension (High Blood Pressure) 01/2022
1	Chronic Renal Insufficiency 10/2019
1	Heart Diseases (Heart Disease) 01/2019
1	Obesity 01/2019
1	Parkinson Disease (Parkinson's Disease) 10/2017
1	Unstable Angina 01/2017
1	Coronary Disease (Coronary Heart Disease) 01/2017
1	Myocardial Infarction 01/2017
1	Dwarfism 02/2015
1	Klinefelter Syndrome (Klinefelter's Syndrome) 11/2012
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 07/2012
1	Osteonecrosis (Kienbock's Disease) 07/2012
1	Malnutrition (Nutritional Deficiencies) 08/2007
1	Chronic Fatigue Syndrome (Myalgic Encephalomyelitis) 03/2005

Drug/Important Bio-Agent (IBA)

9	C-Type Natriuretic Peptide (Peptide, C-Type Natriuretic)IBA 01/2022 - 08/2007
7	NTproCNPIBA 01/2022 - 11/2012
5	Natriuretic PeptidesIBA 01/2020 - 01/2006
4	pro-brain natriuretic peptide (1-76)IBA 01/2019 - 11/2012
2	C-Reactive ProteinIBA 01/2020 - 08/2013
2	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2020 - 11/2012
2	Atrial Natriuretic Factor (ANF)IBA 01/2017 - 01/2006
2	atrial natriuretic factor receptor BIBA 02/2015 - 04/2006
2	atrial natriuretic factor receptor CIBA 02/2015 - 04/2006
2	Peptides (Polypeptides)IBA 08/2013 - 11/2012
1	Ascorbic Acid (Vitamin C)FDA LinkGeneric 01/2022
1	CollagenIBA 01/2022
1	vosoritideIBA 12/2021
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	LipidsIBA 01/2020
1	Atorvastatin (Lipitor)FDA Link 01/2020
1	Endothelin-1 (Endothelin 1)IBA 01/2020
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2020
1	4-nitrophenylphosphorylcholine (NPPC)IBA 10/2019
1	CreatinineIBA 10/2019
1	AlbuminsIBA 10/2019
1	Threonine (L-Threonine)FDA Link 01/2019
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 02/2015
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 02/2015
1	SteroidsIBA 07/2012
1	Biomarkers (Surrogate Marker)IBA 07/2012
1	Opioid Analgesics (Opioids)IBA 03/2005

Therapy/Procedure

2	Therapeutics 12/2021 - 01/2020
1	Drug Therapy (Chemotherapy) 07/2012